Birdwatch Note Rating
2022-08-09 05:57:48 UTC - HELPFUL
Rated by Participant: DBDD7CB9B244CA728087AB7BAE1137BC73A7F695DAA7FD2C5FE0D4CE5276519A
Participant Details
Original Note:
The FDA has already announced that it will not require BA.4/5 vaccine trials to be completed before authorizing redesigned boosters for those variants, and is willing to authorize BA.4/5 boosters based on trials for other vaccine variants, so the September date is realistic. https://www.reuters.com/business/healthcare-pharmaceuticals/fda-will-not-require-clinical-trial-data-authorize-redesigned-covid-boosters-2022-06-30/
All Note Details